Close
Smartlab Europe
Inizio Ignite

Pfizer introduces new line of dietary supplements

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Lilly Zepbound-Taltz Combo Gains Ground with Phase 3b Data

Eli Lilly said that its weight-loss medicine Zepbound, when...

J&J to Invest $1 Billion in Pennsylvania Cell Therapy Plant

Johnson & Johnson announced that it plans to invest...

Precision Cellular Analysis Powering the Next Generation

Biopharmaceutical innovation increasingly depends on understanding biology at the...
- Advertisement -
Smart Lab Europe

Pfizer Consumer Healthcare has introduced a new line of dietary supplements ProNutrients, which are formulated to naturally work with a multivitamin.The dietary supplements include Omega-3, Probiotic, and Fruit & Veggie.

Omega-3 provides two Omega-3s (according to Eicosapentaenoic Acid/EPA and Docosahexaenoic Acid/DHA standards) in an ultra-concentrated MiniGel.Omega-3, due to its smaller size, is easy to swallow and support heart health, brain structure and eye structure, claims the company.

New ProNutrients Fruit & Veggie is obtained from grapes, blueberries, raspberries, plums, carrots and tomatoes which support cell protection and general health.

Moreover, the new Probiotic is a blend of powders wrapped in packets and are designed to ensure the bacteria arrive active and ready to work in the digestive tract and support immune health and digestive balance.The company has also introduced Centrum Specialist with specific benefits includes Prenatal, Vision, Energy and Heart.

 

Smart Lab Europe

Latest stories

Related stories

Lilly Zepbound-Taltz Combo Gains Ground with Phase 3b Data

Eli Lilly said that its weight-loss medicine Zepbound, when...

J&J to Invest $1 Billion in Pennsylvania Cell Therapy Plant

Johnson & Johnson announced that it plans to invest...

Precision Cellular Analysis Powering the Next Generation

Biopharmaceutical innovation increasingly depends on understanding biology at the...

FDA Approves Monthly Rybrevant Faspro for EGFR-Mutated NSCLC

Johnson & Johnson (J&J) has obtained approval from the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »